Rocket Lab (NASDAQ:RKLB) Upgraded to “Hold” at Wells Fargo & Company

Wells Fargo & Company upgraded shares of Rocket Lab (NASDAQ:RKLB) to a hold rating in a report issued on Tuesday,Zacks.com reports.

Other research analysts also recently issued reports about the company. KeyCorp downgraded Rocket Lab from an “overweight” rating to a “sector weight” rating in a research note on Thursday, January 15th. Wall Street Zen raised Rocket Lab from a “sell” rating to a “hold” rating in a report on Sunday, February 8th. Stifel Nicolaus lifted their price objective on shares of Rocket Lab from $75.00 to $85.00 and gave the stock a “buy” rating in a research report on Monday, December 22nd. The Goldman Sachs Group increased their price objective on shares of Rocket Lab from $47.00 to $69.00 and gave the company a “neutral” rating in a research report on Tuesday, January 20th. Finally, TD Cowen restated a “buy” rating on shares of Rocket Lab in a research note on Thursday, January 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $79.42.

Rocket Lab Price Performance

Shares of NASDAQ RKLB opened at $65.52 on Tuesday. The company has a quick ratio of 3.61, a current ratio of 4.08 and a debt-to-equity ratio of 0.10. The business’s 50 day moving average price is $72.19 and its two-hundred day moving average price is $64.81. The company has a market cap of $37.18 billion, a PE ratio of -177.08 and a beta of 2.20. Rocket Lab has a twelve month low of $14.71 and a twelve month high of $99.58.

Insiders Place Their Bets

In other Rocket Lab news, SVP Arjun Kampani sold 28,761 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $69.59, for a total value of $2,001,477.99. Following the completion of the sale, the senior vice president owned 421,699 shares of the company’s stock, valued at $29,346,033.41. The trade was a 6.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Frank Klein sold 100,000 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $72.95, for a total transaction of $7,295,000.00. Following the transaction, the insider owned 1,169,487 shares in the company, valued at approximately $85,314,076.65. The trade was a 7.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,807,614 shares of company stock valued at $136,326,621 in the last three months. Insiders own 11.90% of the company’s stock.

Institutional Investors Weigh In On Rocket Lab

Hedge funds and other institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC lifted its position in shares of Rocket Lab by 114.0% during the 1st quarter. AQR Capital Management LLC now owns 174,308 shares of the rocket manufacturer’s stock valued at $3,117,000 after acquiring an additional 92,849 shares during the period. NewEdge Advisors LLC raised its position in Rocket Lab by 1,812.1% during the first quarter. NewEdge Advisors LLC now owns 36,807 shares of the rocket manufacturer’s stock valued at $658,000 after purchasing an additional 34,882 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Rocket Lab by 53.8% during the first quarter. Jones Financial Companies Lllp now owns 15,745 shares of the rocket manufacturer’s stock worth $282,000 after purchasing an additional 5,507 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Rocket Lab by 13.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 773,548 shares of the rocket manufacturer’s stock worth $13,831,000 after purchasing an additional 90,758 shares during the last quarter. Finally, Focus Partners Wealth boosted its holdings in shares of Rocket Lab by 1.0% in the 1st quarter. Focus Partners Wealth now owns 67,584 shares of the rocket manufacturer’s stock valued at $1,206,000 after purchasing an additional 681 shares in the last quarter. 71.78% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Germany’s regulatory approval for Rocket Lab’s acquisition of Mynaric clears a key hurdle for the deal, improving Rocket Lab’s laser-comm/supply-chain position and prompting analyst bullishness. Rocket Lab (RKLB) Stock Soars 12% as Germany Greenlights Mynaric Acquisition
• Positive Sentiment: A record ~US$190M hypersonic HASTE contract with the U.S. Department of Defense boosts multi‑year contracted revenue and defense backlog visibility, supporting revenue predictability beyond commercial launches. Does Rocket Lab’s Record Hypersonic Test Deal Redefine the Bull Case for RKLB?
• Positive Sentiment: Sector-level tailwinds: reports that SpaceX confidentially filed for an IPO and NASA’s Artemis II launch have lifted sentiment across space stocks, providing short‑term demand for RKLB shares. Rocket Lab Stock Rises As SpaceX IPO Filing Reignites Space Sector Optimism
• Positive Sentiment: Operational/governance positives: CEO Peter Beck took a sizeable pay cut and the company highlights a $1.85B backlog, both of which underline spending discipline and near‑term revenue visibility. Rocket Lab CEO Peter Beck makes a statement as he takes a $799,999 pay cut
• Neutral Sentiment: New coverage: Wells Fargo initiated coverage with an Equal‑Weight rating and a $60 price target (below current levels), signaling a balanced risk/reward view rather than a conviction buy. Wells Fargo initiates coverage of Rocket Lab (RKLB) with equal-weight recommendation
• Neutral Sentiment: Analyst views are mixed: some firms (Roth/MKM, Stifel) see significant growth potential and have higher targets, while others flag execution and valuation risks — producing divergent guidance for investors. Rocket Lab (RKLB) Stock Faces Mixed Forecast as Roth MKM Sees ‘Significant Growth Potential’ While Wells Fargo Cites ‘Balanced Risk/Reward’
• Negative Sentiment: Potential dilution: Rocket Lab filed a large share sale program (reported as ~$1B), which could weigh on the stock if shares are issued at current prices — investors will watch how any proceeds are deployed. Prediction: Rocket Lab Could Soar if This $1 Billion Bet Pays Off
• Negative Sentiment: Execution/timing risk remains: analysts warn Neutron development/deployment timing, supplier constraints and margin pressure could create volatility despite strong backlog. Rocket Lab Stock: Neutral View Amid Strong Demand and Execution Risks

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.